Charles Henderson

1.6k total citations
30 papers, 723 citations indexed

About

Charles Henderson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Charles Henderson has authored 30 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Charles Henderson's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Charles Henderson is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Charles Henderson collaborates with scholars based in United States, Canada and Australia. Charles Henderson's co-authors include Luis Chu, Ronald M. Bukowski, Walter M. Stadler, Sébastien J. Hotte, Tamila L. Kindwall‐Keller, Robert A. Figlin, Janice P. Dutcher, Harry A. Drabkin, Jennifer J. Knox and Chenghua Xia and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Charles Henderson

29 papers receiving 704 citations

Peers

Countries citing papers authored by Charles Henderson

Since Specialization

Citations

This map shows the geographic impact of Charles Henderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Henderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Henderson more than expected).

Fields of papers citing papers by Charles Henderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Henderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Henderson. The network helps show where Charles Henderson may publish in the future.

Co-authorship network of co-authors of Charles Henderson

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Henderson. A scholar is included among the top collaborators of Charles Henderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Henderson. Charles Henderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Regorafenib for previously treated metastatic colorectal cancer (mCRC): A subgroup analysis of 364 patients in the USA treated in the international, open-label phase IIIb CONSIGN study. 2016 ·Journal of Clinical Oncology ·Udit Verma, Yull Arriaga, Heinz‐Josef Lenz, Charles Henderson, Jyotsna Fuloria, Thomas H. Cartwright, Ali Khojasteh, Philip J. Stella, Marc Saltzman, Allen Lee Cohn, Philip Agop Philip, Christian Kappeler, J. Kalmus, Axel Grothey, Eric Van Cutsem, Howard S. Höchster, Francis P. Arena	1
2	Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium 2015 ·Journal of Clinical Oncology ·Manish A. Shah, Yelena Y. Janjigian, Ronald G. Stoller, Stephen Shibata, Margaret Kemeny, Smitha Krishnamurthi, Yungpo Bernard Su, Allyson J. Ocean, Marinela Capanu, Bhoomi Mehrotra, Paul S. Ritch, Charles Henderson, David P. Kelsen	117
3	A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer 2013 ·Breast Cancer Research and Treatment ·Shanu Modi, Cristina Saura, Charles Henderson, Nancy U. Lin, Reshma Mahtani, Jill Goddard, Eduard Ródenas‐Alesina, Clifford A. Hudis, Joyce O’Shaughnessy, José Baselga	51
4	Safety and Efficacy of Sorafenib in Elderly Patients Treated in the North American Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program 2010 ·Oncology ·Ronald M. Bukowski, Walter M. Stadler, David F. McDermott, Janice P. Dutcher, Jennifer J. Knox, Wilson H. Miller, John D. Hainsworth, Charles Henderson, Julio Hajdenberg, Tamila L. Kindwall‐Keller, Marc S. Ernstoff, Harry A. Drabkin, Brendan D. Curti, Luis Chu, Christopher W. Ryan, Sébastien J. Hotte, Chenghua Xia, Lisa Cupit, Robert A. Figlin	33
5	Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America 2010 ·Cancer ·Walter M. Stadler, Robert A. Figlin, David F. McDermott, Janice P. Dutcher, Jennifer J. Knox, Wilson H. Miller, John D. Hainsworth, Charles Henderson, (unknown), Julio Hajdenberg, Tamila L. Kindwall‐Keller, Marc S. Ernstoff, Harry A. Drabkin, Brendan D. Curti, Luis Chu, Christopher W. Ryan, Sébastien J. Hotte, Chenghua Xia, Lisa Cupit, Ronald M. Bukowski	193
6	Addressing Student Difficulties with Concepts Related to Entropy, Heat Engines and the Carnot Cycle 2009 ·AIP conference proceedings ·(unknown), Warren M. Christensen, John R. Thompson, Mel Sabella, Charles Henderson, Chandralekha Singh	16
7	Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma 2009 ·Investigational New Drugs ·Jennifer Wu, Charles Henderson, Lynn G. Feun, Peter J. Van Veldhuizen, Philip J. Gold, Hui Zheng, Theresa Ryan, Lawrence S. Blaszkowsky, Haobin Chen, Max Costa, Barry P. Rosenzweig, (unknown), Howard S. Höchster, Franco M. Muggia, Giovanni Abbadessa, Jonathan J. Lewis, Andrew X. Zhu	33
8	The Effect of an Inquiry-Based Early Field Experience on Pre-Service Teachers’ Content Knowledge and Attitudes Toward Teaching 2009 ·AIP conference proceedings ·Homeyra R. Sadaghiani, (unknown), Mel Sabella, Charles Henderson, Chandralekha Singh	4
9	The Effect of Initial Conditions and Discussion on Students’ Predictions for Interactive Lecture Demonstrations 2008 ·AIP conference proceedings ·Jeffrey Marx, Charles Henderson, Mel Sabella, Leon Hsu	0
10	Student Understanding Of The Physics And Mathematics Of Process Variables In P-V Diagrams 2007 ·AIP conference proceedings ·(unknown), John R. Thompson, Donald B. Mountcastle, Leon Hsu, Charles Henderson, Laura McCullough	43
11	The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial: Subset analysis of patients (pts) with brain metastases (BM) 2007 ·Journal of Clinical Oncology ·Charles Henderson, Ronald M. Bukowski, Walter M. Stadler, Janice P. Dutcher, Tamila L. Kindwall‐Keller, Sébastien J. Hotte, (unknown), (unknown), Kathy Wilson, Robert A. Figlin	21
12	An open-label multicenter phase II study of oral lapatinib (GW572016) as single agent, second-line therapy in patients with metastatic colorectal cancer 2005 ·Journal of Clinical Oncology ·Anthony Fields, David Rinaldi, Charles Henderson, Colin Germond, Luis Chu, (unknown), L. Leopold, M. S. Berger	43
13	Anti-epidermal growth factor (EGFR) antibody, cetuximab, in patients with stage IV colorectal carcinoma who failed all standard therapy: Final report of an access protocol 2005 ·Journal of Clinical Oncology ·Gary Spitzer, (unknown), Philip J. Stella, Lee M. Zehngebot, Charles Henderson	4
14	Cetuximab plus FOLFOX for colorectal cancer (EXPLORE): Preliminary safety analysis of a randomized phase III trial 2004 ·Journal of Clinical Oncology ·(unknown), Edith P. Mitchell, (unknown), (unknown), Vincent Hansen, Charles Henderson, (unknown), (unknown)	8
15	Preclinical testing of a peptide-based, HER2/neu vaccine for prostate cancer 2004 ·International Journal of Oncology ·Michael Woll, Matthew T. Hueman, (unknown), Constantin G. Ioannides, Charles Henderson, (unknown), (unknown), David G. McLeod, Judd W. Moul, George E. Peoples	8
16	Cetuximab plus FOLFOX for colorectal cancer (EXPLORE): Preliminary safety analysis of a randomized phase III trial 2004 ·Journal of Clinical Oncology ·(unknown), Edith P. Mitchell, (unknown), (unknown), Vincent Hansen, Charles Henderson, (unknown), (unknown)	4
17	Acute Pulmonary Edema in a Young Male After Intravenous Nalmefene 1997 ·Anesthesia & Analgesia ·Charles Henderson, John E. Reynolds	12
18	Multiple Myeloma With Hairy Cell–Like Features 1997 ·American Journal of Clinical Pathology ·(unknown), (unknown), Charles Henderson, Peter M. Banks, Fiona E. Craig	4
19	Ondansetron for nausea and vomiting associated with moderately emetogenic cancer chemotherapy 1995 ·Clinical Therapeutics ·(unknown), Luigi X. Cubeddu, Thomas Ryan, Julie A. Kish, (unknown), (unknown), Peter D. Eisenberg, Charles Henderson, (unknown), (unknown)	11
20	The Principal Speaks 1966 ·Childhood Education ·Charles Henderson	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact